Biophytis – Convening of Another Combined General Meeting at a Later DateRead the press release
Biophytis gives operational perspectives on its Sarconeos (BIO101) ahead of its upcoming AGM on April 26, 2021Read the presse release
Interview of Stanislas Veillet, CEO of Biophytis on La Bourse ou la Vide.com (in French).
Biophytis Identifies False Report Regarding COVA StudyRead the Press Release
Stanislas Veillet, CEO of Biophytis, reviews the company’s latest news in this interview with Laurent Grassin from Journal des Biotechs, covering listing on Nasdaq, Covid-19 clinical studies, expected clinical data in sarcopenia and the legal case with Negma. You can see the interview here